All articles
Examining the effectiveness of a new digital care model on weight loss for people living with obesity
This real-world evaluation of more than 2,600 patients in Sweden showed that Yazen’s comprehensive digital obesity care model achieved 12.6% weight loss after 6 months, alongside significant improvements in cardiometabolic health markers. The model combines GLP-1 treatment, lifestyle intervention, and continuous multidisciplinary support through a digital platform designed for long-term obesity care.
Ozempic and diet: Are there any foods you should avoid?
Modern medical treatment for overweight and obesity helps many people lose weight, improve their health, and maintain a lower weight over time. However, some experience side effects such as nausea, heartburn, or constipation. For most people, these symptoms are most common at the beginning of treatment and during dose increases. The side effects are usually mild and can often be prevented.
